Catalent Biologics Content
-
Achieving A Successful Drug Product Technology Transfer
Get insights on key considerations for a successful process transfer for manufacturing a drug product, including a case study on overcoming challenges in a process transfer for a sterile diluent.
-
Getting Your Biologic To Clinic Faster & More Efficiently
There are a range of benefits to use an integrated supplier to streamline biologic drug development starting in early phase through clinical and commercial stages.
-
European Center Of Excellence For Clinical Biologics
Explore how our proven expertise and simplified execution with development, filling, and analytical under one roof ensure safe, efficacious products reach patients in need.
-
Keys To A Successful Rapid Commercial Launch
Combining a rapid launch following regulatory approval with effective messaging and post-launch services can provide a competitive advantage.
-
SMARTag Technology, From Bertozzi Lab To Best-In-Class ADCs
Hear experts discuss the latest trends in antibody-drug conjugate (ADC) discovery and development and how next-generation pipelines are being shaped by payload and linker-chemistry innovations.
-
A Guide To Optimize Analytical Strategies Throughout The Biologics Development Life Cycle
A miscalculated analytical approach can be costly to develop, perform, and maintain. Many organizations also lack appropriate resources to create optimal testing methods and protocols.
-
Reaching First-In-Human Trials Faster: Connect With The Right Partner
Assessing outsourcing partners’ credentials in people, technology, supply chains, and integration will make all the difference as sponsors aim to streamline processes on the path to commercialization.
-
Get Your Biologic To Clinic And Market Faster
We are your one integrated partner with the expertise to get your therapeutic product to market faster, helping you accelerate, simplify, and de-risk your biologics.
-
Transitioning From Vial To Prefilled Syringe
Understand how formulation development for a prefilled syringe affects manufacturing, driving the industry toward optimizing delivery of injectable products and, ultimately, improving patient care.